Malignant acanthosis nigricans and endometrioid adenocarcinoma of the parametrium: The search for malignancy

Journal of the American Academy of Dermatology

Volumn 49, Issue 3, 2003, Pages 541-543

  Longshore, Sharon J ^a,b   Taylor, James S ^a   Kennedy, Alexander ^a   Nurko, Saul ^a  

^a NONE

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ACANTHOSIS NIGRICANS; AGED; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; ENDOMETRIOID CARCINOMA; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; LAPAROSCOPY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SKIN MANIFESTATION;

EID: 0042827433     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)00913-7     Document Type: Article

References (9)

1. Pollitzer S. Acanthosis nigricans. In: Unna PG, editor. International atlas of rare skin diseases. Part 4. London: HK Lewis and Co; 1890. p. 6.
2. Janovsky V. Acanthosis nigricans. In: Unna PG, editor. International atlas of rare skin diseases. Part 1. London: HK Lewis and Co; 1890. p. 1.
3. Schwartz RA. Acanthosis nigricans, florid cutaneous papillomatosis and the sign of Leser-Trélat. Cutis 1981;28:319-31.
4. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol 1994;31:1-9.
5. Curth HO, Wilberg AW, Machacek GF. The site and histology associated with acanthosis nigricans. Cancer 1962;15:364-82.
6. Curth HO. Significance of acanthosis nigricans. Arch Dermatol 1952;66:80.
7. Flier JS. Metabolic importance of acanthosis nigricans [editorial]. Arch Dermatol 1985;121:193-4.
8. Ellis DL, Kafka SP, Chow JC, Nanney LB, Inman WH, McCadden ME, King LE Jr. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons: a possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 1987;317:1582-7.
9. Stone OJ. Acanthosis nigricans-decreased extracellular matrix viscosity: cancer, obesity, diabetes, corticosteroids, somatotrophin. Med Hypotheses 1993;40:154-7.